Biotie Therapies (BTH1V) Company Profile - CorporateInformation.com


	The Wright Reports site is no longer hosted or operated by Manta. Please review the following: 1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing. 2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com 3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp 4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)

Biotie Therapies Company Snapshot

Business Description:

Biotie Therapies operates in the Pharmaceutical preparations sector. Biotie Therapies Oyj (Biotie Therapies Corporation) is a Finland-based biopharmaceutical company. It is a drug discovery and development company focused on central nervous system and inflammatory diseases. It has a broad range of small molecule and biological drug candidates at different stages of clinical and pre-clinical development. Biotie's products address diseases with high unmet medical need, including addiction and psychotic disorders, rheumatoid arthritis, psoriasis and chronic obstructive pulmonary disease (COPD). The Company has alliances with global pharmaceutical companies such as Lundbeck, Roche and Pfizer (formerly Wyeth). The company has two non-operational subsidiaries Biotie Therapies GmbH, located in Radebeul, Germany and Biotie Therapies International Ltd in Finland. In our complete report available for purchase the company is compared to: Curasan AG, Merrion Pharmaceuticals Plc and Nicox SA.

Biotie Therapies

Stock Data:

Recent Stock Performance:

Current Price (2/3/2012): .49
(Figures in Euro)

1 Week	-2.0%	13 Weeks	-2.0%

4 Weeks	2.1%	52 Weeks	-10.9%

Biotie Therapies Key Data:

Ticker:	BTH1V	Country:	FINLAND

Exchanges:	DUS FRA HEL OTH	Major Industry:	Miscellaneous

		Sub Industry:	Medical Services

2010 Sales	1,955,000 (Year Ending Jan 2011).	Employees:	23

Currency:	Euro	Market Cap:	184,327,280

Fiscal Yr Ends:	December	Shares Outstanding:	376,178,122

Share Type:	Osake	Closely Held Shares:	1,682,588

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.